Johnson & Johnson's COVID-19 vaccine will remain in limbo for a while longer after government health advisers declared Wednesday that they need more evidence to decide if a handful of unusual blood clots were linked to the shot — and if so, how big the risk really is.
Iran will begin enriching uranium up to 60% purity after an attack on its Natanz nuclear facility, a negotiator said Tuesday, pushing its program to higher levels than ever before though still remaining short of weapons-grade.
Iran's nuclear program has been targeted by diplomatic efforts and sabotage attacks over the last decade, with the latest incident striking its underground Natanz facility.
The attack Sunday at Natanz comes as world powers try to negotiate a return by Iran and the U.S. to Tehran's atomic accord. The sabotage threatens to upend those negotiations and further heighten regional tensions across the Mideast.
Yuri Gagarin's pioneering, single-orbit flight made him a hero in the Soviet Union and an international celebrity. After putting the world's first satellite into orbit with the successful launch of Sputnik in October 1957, the Soviet space program, rushed to secure its dominance over the United States by putting a man into space.
Military teams across the U.K. and on ships at sea fired 41-gun salutes Saturday to mark the death of Prince Philip, honoring the former naval officer and husband of Queen Elizabeth II who they considered one of their own.
Preliminary results from two experiments suggest something could be wrong with the basic way physicists think the universe works, a prospect that has the field of particle physics both baffled and thrilled.
China’s top disease control official, in a rare acknowledgement, said current vaccines offer low protection against the coronavirus and mixing them is among strategies being considered to boost their effectiveness.
The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
A top official at the European Medicines Agency says there is a causal link between AstraZeneca's coronavirus vaccine and rare blood clots, but that it's unclear what the connection is and the benefits of taking the shot still outweigh the risks of getting COVID-19.